Editors' Desk

  1. 3 [Potential] Solutions To A More Resilient Supply Chain 10/16/2025

    In her opening presentation, Harney noted that there were 98 drug shortages in 2024, 40 medicines in shortage for over three years, and the average duration of a shortage has increased from three years to four years.

  2. Extreme Weather Is Testing Pharma's Resilience — Is It Ready? 10/14/2025

    It may sound like a stretch, but researchers from Harvard University showed how a disproportionate amount of pharmaceutical manufacturers are in areas of climate-driven extreme weather events. Is the pharmaceutical industry currently set up to withstand them?  

  3. Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma 10/6/2025

    Researchers at the University of Maine may have found a way to do two out of three by developing a new method of producing (S)-3-hydroxy-γ-butyrolactone (HBL) for statins, HIV inhibitors and antibiotics that can lower their production cost with an added benefit of reducing their carbon footprint.

  4. Roll Call In The Oral GLP-1 Race 9/26/2025

    The market for GLP-1 agonists is booming and expected to only get bigger. As rates for obesity and cardiovascular disease increase, so too does the demand for GLP-1 drugs.

  5. From Lab to Plant: Managing Operational Environment During Scale-Up 9/18/2025

    Though these challenges can result from equipment, raw material differences, and process variability, operational environments must be a major focus during lab trials, as Yuhei Yamamoto and his team at Takeda learned in a recent experience.

  6. 10 Ways To Strengthen U.S. API: Part II 9/4/2025

    We continue the API supply chain conversation, jumping into KSM sourcing and substitution, utilizing idle space and connecting the dots. The road to strengthening the U.S. pharmaceutical supply chain won’t be easy, but it is manageable.

  7. 10 Ways To Strengthen U.S. API: Part I 8/29/2025

    Bringing the API supply chain closer to home not only strengthens the supply chain for U.S. drug makers, but it also strengthens the U.S. reserve of critical medicines.

  8. Reimagining Psychedelics: Mental Wellness Without the Roadblocks 8/19/2025

    The rising incidence of mental health disorders brought the mental health benefits of psychedelics back into the spotlight, and we are currently at a watershed moment.

  9. Gedatolisib Shatters Phase 3 Goals and Scales For Breast Cancer Breakthrough 8/11/2025

    After unprecedented phase 3 clinical trails of gedatolisib, Celcuity is working feverishly with its partners to get the drug ready to offer a new standard of care to those that suffer from advanced breast cancer.

  10. The Rise Of NAMs 7/31/2025

    New Approach Methods (NAMs) are rapidly being accepted as replacements for preclinical animal tests long considered to be the gold standard. NAMs include systems of organoids, organs-on-chips, AI-based prediction models, and non-mammalian species.